Your browser doesn't support javascript.
loading
Naturally Occurring Telomerase-Specific CD4 T-Cell Immunity in Melanoma.
Nardin, Charlée; Laheurte, Caroline; Puzenat, Eve; Boullerot, Laura; Ramseyer, Mélanie; Marguier, Amélie; Jacquin, Marion; Godet, Yann; Aubin, François; Adotevi, Olivier.
  • Nardin C; Department of Dermatology, University Hospital of Besancon, Besancon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France.
  • Laheurte C; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France; INSERM CIC 1431, Clinical Investigation Center in Biotherapy, Biomonitoring Plateform, Besancon, France.
  • Puzenat E; Department of Dermatology, University Hospital of Besancon, Besancon, France.
  • Boullerot L; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France; INSERM CIC 1431, Clinical Investigation Center in Biotherapy, Biomonitoring Plateform, Besancon, France.
  • Ramseyer M; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France.
  • Marguier A; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France.
  • Jacquin M; INSERM CIC 1431, Clinical Investigation Center in Biotherapy, Biomonitoring Plateform, Besancon, France.
  • Godet Y; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France.
  • Aubin F; Department of Dermatology, University Hospital of Besancon, Besancon, France; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France.
  • Adotevi O; INSERM, EFS BFC, UMR1098, RIGHT, University of Burgundy Franche-Comte, Besancon, France; INSERM CIC 1431, Clinical Investigation Center in Biotherapy, Biomonitoring Plateform, Besancon, France; Department of Medical Oncology, University Hospital of Besancon, Besancon, France. Electronic address: oli
J Invest Dermatol ; 142(2): 435-444, 2022 02.
Article en En | MEDLINE | ID: mdl-34352265

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Células TH1 / Telomerasa / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Células TH1 / Telomerasa / Inhibidores de Puntos de Control Inmunológico / Melanoma Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2022 Tipo del documento: Article